The Searle Company Limited (SEARL): Synergies to payoff – By JS Research
- The Searle Company Limited (SEARL):
- The Searle Company Limited (SEARL) is all geared up to expand its top-line in the coming year through increase in export footprint and volumetric growth.
- The company expects profit contribution from OBS Pharma to double in FY22, while its IPO is expected by Feb-2022.
- SEARL posted a consolidated profit after tax of Rs3.7bn (EPS: Rs12.1) in FY21 compared to a profit of Rs2.5bn (EPS: Rs8.16) in the SPLY mainly due to 28% YoY higher sales and other income of Rs800mn booked under gain on disposal of subsidiary. For 1QFY22, the company witnessed sales growth of 38% YoY and posted a bot...
